AAOMS Annual Meeting

Conference Coverage

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

opioids
opioids
Abuse-Deterrent Opioid Receives FDA Approval
04/26/2017
The first immediate-release opioid to receive abuse-deterrent labeling was recently approved by the FDA.
04/26/2017
opioids
opioids
Abuse-Deterrent Opioid Receives FDA Approval
04/26/2017
The first immediate-release opioid to receive abuse-deterrent labeling was recently approved by the FDA.
04/26/2017
opioids
opioids
Abuse-Deterrent Opioid Receives FDA Approval
04/26/2017
The first immediate-release opioid to receive abuse-deterrent labeling was recently approved by the FDA.
04/26/2017
FDA
FDA
FDA Approves First Methotrexate Oral Solution
04/26/2017
The FDA has approved Xatmep, an oral solution for the treatment of acute lymphoblastic leukemia and polyarticular juvenile idiopathic arthritis.
04/26/2017
Lipids
Lipids
FDA Approves New Dosing Option for Praluent
04/25/2017
The FDA has approved a new, monthly dosing option for the PCSK9-inhibitor Praluent (alirocumab).
04/25/2017
Lipids
Lipids
FDA Approves New Dosing Option for Praluent
04/25/2017
The FDA has approved a new, monthly dosing option for the PCSK9-inhibitor Praluent (alirocumab).
04/25/2017
Lipids
Lipids
FDA Approves New Dosing Option for Praluent
04/25/2017
The FDA has approved a new, monthly dosing option for the PCSK9-inhibitor Praluent (alirocumab).
04/25/2017
Treatment
Treatment
FDA: New Indication for Thymoglobulin
04/24/2017
The FDA has approved a new indication for the drug Thymoglobulin, for use in patients undergoing kidney transplant.
04/24/2017
FDA
FDA
New Biosimilar Approved by the FDA
04/24/2017
The US Food and Drug Administration recently approved the second biosimilar to Remicade for the treatment of immune-disorders.
04/24/2017
FDA
FDA
New Biosimilar Approved by the FDA
04/24/2017
The US Food and Drug Administration recently approved the second biosimilar to Remicade for the treatment of immune-disorders.
04/24/2017